These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8288088)

  • 41. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
    Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
    Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.
    Scheler M; Proelss J; Bräuninger W; Bieber T; Wenzel J
    Dermatology; 2007; 215(3):236-9. PubMed ID: 17823522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
    Payen JL
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S175-89. PubMed ID: 9161529
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
    Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
    An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Serum smooth muscle antibodies with anti-actin specificity appeared during treatment with interferon alpha].
    Grimbert S; Mohib S; Johannet C; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 1996; 20(4):404-5. PubMed ID: 8758511
    [No Abstract]   [Full Text] [Related]  

  • 47. [The advances in the treatment of chronic hepatitis C with interferon].
    Liu TH; Fu XX; Tian GS
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):650-2. PubMed ID: 1306461
    [No Abstract]   [Full Text] [Related]  

  • 48. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral lichenoid reactions versus lichen planus.
    Giunta JL
    J Mass Dent Soc; 2001; 50(2):22-5. PubMed ID: 11494461
    [No Abstract]   [Full Text] [Related]  

  • 50. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 51. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic hepatitis C: therapeutic uncertainties].
    Blondon H; Bergmann JF
    Gastroenterol Clin Biol; 1996; 20(12):1043-6. PubMed ID: 9033847
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.
    Castilla A; Castilla I; Prieto J
    Am J Gastroenterol; 1993 Mar; 88(3):466-7. PubMed ID: 8438868
    [No Abstract]   [Full Text] [Related]  

  • 56. [Results of treatment of hepatitis C with interferon alone or combined with other drugs].
    Serfaty L
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S154-66. PubMed ID: 9161527
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
    Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lichen planus during chronic hepatitis C treated with interferon alpha].
    d'Agay-Abensour L; Benamouzig R; de Belilovsky C; Cordoliani F; Halphen M; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(6-7):610-1. PubMed ID: 1526425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.